A Multicenter Non-interventional Study for the Measurement of Scratch and Sleep Patterns Using the ADAM Sensor in Patients With Primary Biliary Cholangitis

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

This study will collect information from patients with Primary Biliary Cholangitis (PBC). PBC is a progressive rare liver disease in which tubes in the liver called bile ducts are damaged. The liver damage in PBC may lead to scarring (cirrhosis). People living with PBC often face challenges like intense itching, trouble sleeping, and feeling constantly tired. These symptoms can make it hard for them to enjoy daily life and feel well overall. While itching and sleep patterns can be difficult to measure accurately based on recall and may lack precision, the main aim of this study is to use a digital health tool to assess the severity of itchiness and sleep patterns in people with PBC. The tool will take the objective measurement for people so they do not have to recall their scratch and sleep patterns. The total study duration for each patient will be about 91 days.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Aged 18 years or older at time of study enrollment.

• Confirmed diagnosis of PBC based on medical history and relevant clinical criteria, as determined by the study Investigator.

• Willingness and ability to wear the ADAM sensor during the specified time periods (7 nights across four 7-day periods).

• Able to read and write to ensure accurate completion of electronic PRO surveys.

• Able to access an internet-connected device for the completion of electronic PRO surveys.

• Able to provide signed, informed consent prior to collection of data.

Locations
United States
Arizona
Arizona Liver Center
RECRUITING
Chandler
Florida
University of Miami School of Medicine, Center for Liver Diseases
RECRUITING
Miami
Texas
UT Southwestern Medical Center, Department of Internal Medicine, Digestive and Liver Diseases
RECRUITING
Dallas
Contact Information
Primary
Ipsen Clinical Study Enquiries
clinical.trials@ipsen.com
See Email
Time Frame
Start Date: 2025-07-16
Estimated Completion Date: 2025-12-15
Participants
Target number of participants: 30
Sponsors
Leads: Ipsen

This content was sourced from clinicaltrials.gov

Similar Clinical Trials